s6y
Company name or ticker
Search
Raphael Pharmaceutical Inc.
8-K
Current report filing
Filed
Thursday, May 2, 2024
Period
Apr 30, 2024
Accession number
0001213900-24-039106
Documents
8-K
8-K
XBRL SCHEMA FILE
EX-101.SCH
XBRL LABEL FILE
EX-101.LAB
XBRL PRESENTATION FILE
EX-101.PRE
On sec.gov
Filing index
All files
Complete submission text
SGML header